CWS
HOWL icon

Confluence Wealth Services’s Werewolf Therapeutics HOWL Stock Holding History

Confluence Wealth Services’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$1K – 631
2021
Q4 		$1K Buy
+100
New +$1.51K ﹤0.01% 1188

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Confluence Wealth Services's HOWL Position: Q1 2022 in Review

Confluence Wealth Services sold out of Werewolf Therapeutics (HOWL) in Q1 2022, closing a stake of 100 shares — an estimated $1K sold.

Confluence Wealth Services first reported a position in HOWL in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 49 funds tracked by Wall St. Rank hold HOWL as of Q1 2022.

  • Confluence Wealth Services reported no remaining Werewolf Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Confluence Wealth Services sold 100 Werewolf Therapeutics shares in Q1 2022, an estimated $1K.
  • Confluence Wealth Services first reported a position in Werewolf Therapeutics in Q4 2021 and held it in 1 quarter.
  • Confluence Wealth Services's Werewolf Therapeutics position peaked at $1K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2022.

Based on Confluence Wealth Services's 13F filing for Q1 2022, filed 26 Apr 2022.